systemic therapies in hereditary hemorrhagic telangiectasia current evidence and emerging targets

Original title: “Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets.”

is hereditary hemorrhagic telangiectasia really a rare disease

Original title: “Is hereditary hemorrhagic telangiectasia really a rare disease?”

The startup is one of at least a few young companies zeroing in on the rare bleeding disorder, hereditary hemorrhagic telangiectasia, with a more precise AKT blocker.

Original title: “Vaderis hauls in $152M to test an AKT-targeting drug”

recurrent t 9 12 translocation disrupting acvrl1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated families

Original title: “Recurrent t(9;12) translocation disrupting ACVRL1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated families.”

Atavistik Bio is using the cash to develop “allosteric” medicines it believes can precisely impact on diseases like myelofibrosis and the blood condition HHT.

Original title: “A startup making drugs for blood disorders banks $160M”